Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 12.5759.64-14.83-17.6213.02

What is the latest Core EBITDA Growth ratio of AUROBINDO PHARMA ?

The latest Core EBITDA Growth ratio of AUROBINDO PHARMA is 12.57 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202512.57
Mar202459.64
Mar2023-14.83
Mar2022-17.62
Mar202113.02

How is Core EBITDA Growth of AUROBINDO PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 12.57
-78.92
Mar2024 59.64
Positive
Mar2023 -14.83
Negative
Mar2022 -17.62
Negative
Mar2021 13.02 -

Other Financial Ratios of AUROBINDO PHARMA


Compare Core EBITDA Growth ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹82,420.3 Cr -1.5% 2.6% 21.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,909.0 Cr -2.5% 1% 7.5% Stock Analytics
DIVIS LABORATORIES ₹173,930.0 Cr -3.1% 0.3% -1.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹147,181.0 Cr -4.9% 2.8% 37.8% Stock Analytics
CIPLA ₹112,353.0 Cr -1.6% 5.6% -5.7% Stock Analytics
DR REDDYS LABORATORIES ₹107,608.0 Cr -3.2% -3.1% 4.8% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-1.5%

2.6%

21.3%

SENSEX

-1.5%

-3.4%

-9.1%


You may also like the below Video Courses